Emily M. Leproust
Chief Executive Officer, Director · Twist Bioscience Corp
- 2024
- Oct 7, 2026
- 43
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Emily M. Leproust files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Patrick John Finn - $21.57M in TWST purchases and sales in the last 12 months
- Dennis Cho - $8.78M in TWST purchases and sales in the last 12 months
- Paula Green - $7.22M in TWST purchases and sales in the last 12 months
- Adam Laponis - $4.09M in TWST purchases and sales in the last 12 months
- Robert Chess - $2.62M in TWST purchases and sales in the last 12 months
- Robert F. Werner - $1.49M in TWST purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Emily M. Leproust?
Emily M. Leproust is a corporate insider, tracked as Chief Executive Officer, Director of Twist Bioscience Corp (TWST). InsiderAlpha holds 43 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Emily M. Leproust submitted recently?
11 primary Form 4 filings in the last 90 days, covering 1 company.
Has Emily M. Leproust been buying or selling stock?
Recorded transactions: 0 open-market purchases and 79 open-market sales ($104.93M) across all tracked filings.
